[1]
2026. Tralokinumab versus Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis with Hand Involvement: a Matching-Adjusted Indirect Comparison. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s725. DOI:https://doi.org/10.25251/24g02225.